Association between consumption of Herbalife® nutritional supplements and acute hepatotoxicity

Journal of Hepatology

Volumn 47, Issue 4, 2007, Pages 514-520

  Elinav, Eran ^a   Pinsker, Galia ^c   Safadi, Rifaat ^a   Pappo, Orit ^b   Bromberg, Michal ^c   Anis, Emilia ^c   Keinan Boker, Lital ^c   Broide, Efrat ^a   Ackerman, Zvi ^a   Kaluski, Dorit Nitzan ^c   Lev, Boaz ^c   Shouval, Daniel ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b MINISTRY OF HEALTH   (Israel)

^c ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Hepatitis; Hepatotoxicity; Herbal supplements; Herbalife

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMINOGEN; BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID; HERBACEOUS AGENT; HERBALIFELINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIVER ENZYME; METFORMIN; ORAL CONTRACEPTIVE AGENT; ROSEOX; TANG KUEI PLUS; THERMOJETICS; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ACUTE HEPATITIS; ADULT; AGED; ARTICLE; BILIARY CIRRHOSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; LABORATORY TEST; LIVER BIOPSY; LIVER FAILURE; LIVER INJURY; LIVER TOXICITY; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL;

ADULT; AGED; EPHEDRA; FEMALE; HEPATITIS, TOXIC; HUMANS; ISRAEL; MIDDLE AGED; TREATMENT OUTCOME;

EID: 34548212844     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.06.016     Document Type: Article

References (18)

1. Strader D.B., and Seeff L.B. Zakim and Boyer hepatology. In: Boyer T.D., Wright T.L., and Manns M.P. (Eds). Hepatotoxicity of herbal preparations. 5th ed. (2006), US Saunders - Elsevier, Philadelphia 551-560
2. Eisenberg D.M., Davis R.B., Ettner S.L., Appel S., Wilkey S., Van Rompay M., et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280 (1998) 1569-1575
3. Shaw D., Leon C., Kolev S., and Murray V. Traditional remedies and food supplements. A 5-year toxicological study (1991-1995). Drug Saf 17 (1997) 342-356
4. Stickel F., Patsenker E., and Schuppan D. Herbal hepatotoxicity. J Hepatol 43 (2005) 901-910
5. Estes J.D., Stolpman D., Olyaei A., Corless C.L., Ham J.M., Schwartz J.M., et al. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch Surg 138 (2003) 852-858
6. Abebe W. Herbal medication: potential for adverse interactions with analgesic drugs. J Clin Pharm Ther 27 (2002) 391-401
7. Strader D.B., Bacon B.R., Lindsay K.L., La Brecque D.R., Morgan T., Wright E.C., et al. Use of complementary and alternative medicine in patients with liver disease. Am J Gastroenterol 97 (2002) 2391-2397
8. Sheikh N.M., Philen R.M., and Love L.A. Chaparral-associated hepatotoxicity. Arch Intern Med 157 (1997) 913-919
9. Lekehal M., Pessayre D., Lereau J.M., Moulis C., Fouraste I., and Fau D. Hepatotoxicity of the herbal medicine germander: metabolic activation of its furano diterpenoids by cytochrome P450 3A Depletes cytoskeleton-associated protein thiols and forms plasma membrane blebs in rat hepatocytes. Hepatology 24 (1996) 212-218
10. Gow P.J., Connelly N.J., Hill R.L., Crowley P., and Angus P.W. Fatal fulminant hepatic failure induced by a natural therapy containing kava. Med J Aust 178 (2003) 442-443
11. Woolf G.M., Petrovic L.M., Rojter S.E., Wainwright S., Villamil F.G., Katkov W.N., et al. Acute hepatitis associated with the Chinese herbal product jin bu huan. Ann Intern Med 121 (1994) 729-735
12. Nadir A., Agrawal S., King P.D., and Marshall J.B. Pyrrolizidine alkaloids. Acute hepatitis associated with the use of a Chinese herbal product, ma-huang. Am J Gastroenterol 91 (1996) 1436-1438
13. Neff G.W., Reddy K.R., Durazo F.A., Meyer D., Marrero R., and Kaplowitz N. Severe hepatotoxicity associated with the use of weight loss diet supplements containing ma huang or usnic acid. J Hepatol 41 (2004) 1062-1064
14. Favreau J.T., Ryu M.L., Braunstein G., Orshansky G., Park S.S., Coody G.L., et al. Severe hepatotoxicity associated with the dietary supplement LipoKinetix. Ann Intern Med 136 (2002) 590-595
15. Zaacks S.M., Klein L., Tan C.D., Rodriguez E.R., and Leikin J.B. Hypersensitivity myocarditis associated with ephedra use. J Toxicol Clin Toxicol 37 (1999) 485-489
16. Bajaj J., Knox J.F., Komorowski R., and Saeian K. The irony of herbal hepatitis: Ma-Huang-induced hepatotoxicity associated with compound heterozygosity for hereditary hemochromatosis. Dig Dis Sci 48 (2003) 1925-1928
17. Dansette P.M., Bonierbale E., Minoletti C., Beaune P.H., Pessayre D., and Mansuy D. Drug-induced immunotoxicity. Eur J Drug Metab Pharmacokinet 23 (1998) 443-451
18. Schuppan D., Jia J.D., Brinkhaus B., and Hahn E.G. Herbal products for liver diseases: a therapeutic challenge for the new millennium. Hepatology 30 (1999) 1099-1104